Post-translational modification of p53 in tumorigenesis
Top Cited Papers
- 1 October 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 4 (10), 793-805
- https://doi.org/10.1038/nrc1455
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling PathwayOnline Journal of Public Health Informatics, 2004
- Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genesOncogene, 2004
- MDM2-ARF complex regulates p53 sumoylationOncogene, 2003
- Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305Online Journal of Public Health Informatics, 2003
- ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing RadiationOnline Journal of Public Health Informatics, 2002
- Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of DimersOnline Journal of Public Health Informatics, 2002
- Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilizationNature, 2002
- Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleusNature, 2001
- Inhibition of radiation-induced apoptosis in vitro by tumor promotersBiochemical and Biophysical Research Communications, 1988